IA
DYN icon

IFP Advisors’s Dyne Therapeutics DYN Stock Holding History

IFP Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.3K Buy
3,766
+3,671
+3,864% +$63.3K ﹤0.01% 2076
2025
Q4 		$1.86K Sell
95
-1
-1% -$19 ﹤0.01% 3868
2025
Q3 		$1.21K Buy
+96
New +$1.09K ﹤0.01% 3876
2025
Q2 		– Hold
0
– – – 3942
2025
Q1 		– Sell
-3
Closed -$71 – 4397
2024
Q4 		$71 Buy
+3
New +$89 ﹤0.01% 4145

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

IFP Advisors's DYN Position: Q1 2026 in Review

IFP Advisors increased its Dyne Therapeutics (DYN) stake by 3,864% in Q1 2026, buying an estimated $63.3K and bringing the position to 3,766 shares worth $68.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

IFP Advisors first reported a position in DYN in Q4 2024 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • IFP Advisors held 3,766 shares of Dyne Therapeutics worth $68.3K as of Q1 2026.
  • IFP Advisors bought 3,671 Dyne Therapeutics shares in Q1 2026, an estimated $63.3K.
  • Dyne Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #2076 holding.
  • IFP Advisors first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.